Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Following carotid artery stenting or carotid endarterectomy, rates of restenosis are about 2.5 times higher with stenting, according to French investigators reporting in…
NEW YORK (Reuters Health) – For patients with ST-segment elevated MI undergoing primary percutaneous coronary intervention (PCI), a simple protocol of intracoronary administration of adenosine during the procedure…
NEW YORK (Reuters Health) – Warming local anesthetics to body temperature significantly reduces pain from the injection, according to the results of a meta-analysis conducted by Canadian investigators…
NEW YORK (Reuters Health) – For cough suppression during flexible bronchoscopy, the combination of the sedative propofol and the opiate hydrocodone is safe and works better in terms…
NEW YORK (Reuters Health) – The majority of women who become pregnant after in vitro fertilization (IVF) receives progesterone throughout the first trimester, but that may not be…
NEW YORK (Reuters Health) – A new study provides more evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome (ACS). In the…
Did you miss ePharma Summit 2011 in New York, NY? Don’t worry, The Doctor’s Channel has you covered. Get all of the highlights from the meeting right here.…
David Pogue, Tech Columnist for The New York Times, talks about new apps and gadgets for doctors. For more information on David’s Tech Blog, please visit: Pogue.Blogs.NYTimes.com For…
Peter Diamandis, MD, Founder and Chairman of the X PRIZE Foundation, talks about accelerating technologies in healthcare and the practice of medicine. For more information on the X…
NEW YORK (Reuters Health) – Among women treated for early, endocrine-responsive breast cancer, adjuvant therapy with the aromatase inhibitor letrozole leads to better overall survival than does tamoxifen,…
